The state’s instinct to cover up shows little sign of abating
A toxic culture of defensiveness persists in parts of the military and NHS, as recent tragedies highlight
Related Articles
Dismantling of Education Department puts future of trillions of dollars in student loans in question | CNN Politics
As President Donald Trump prepares to order the dismantling of the Department of Education, the financial arm of the agency – which makes loans directly…
Efficacy assessment in phase I clinical trials: endpoints and challenges
The scope of phase I clinical trials in oncology goes beyond the conventional safety evaluation–only objectives of these trials in other specialties. Rather, most first-in-human…
Testicular Germ Cell Tumors
This Review summarizes current evidence regarding risk factors, diagnosis, and treatment of testicular cancer, particularly germ cell tumors, in adults and adolescents.
L’Inserm solidaire du mouvement Stand Up For Science – Salle de presse de l’Inserm
L’Inserm est solidaire du mouvement Stand Up For Science et est solidaire de tous les scientifiques exerçant aux États-Unis, où la liberté académique est aujourd’hui…
AI Snake Oil
From two of TIME’s 100 Most Influential People in AI, what you need to know about AI—and how to defend yourself against bogus AI claims…
The Drug Development Letter | Vinay Prasad | Substack
We cover all aspects of pharmaceutical drug development; early, late phase and FDA pivotal trials; Focus on oncology, but also cover important cardiology, neurology and…
Skills Lab: Interpreting Clinical Research with Bishal Gyawali – Index
Read full-text medical journal articles from Medscape’s Skills Lab: Interpreting Clinical Research with Bishal Gyawali.
Skills Lab: The Importance of the Primary Endpoint
Dr Bishal Gyawali discusses the importance of the primary endpoint in phase 3 clinical trials.
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
Nature Medicine – An updated analysis of the DYNAMIC biomarker-driven trial, including mature survival data at 5 years, supports a ctDNA-guided approach to adjuvant chemotherapy…
Hallmarks of artificial intelligence contributions to precision oncology
Nature Cancer – Ruppin and colleagues overview recent research on the use of AI frameworks in precision oncology, describe ten hallmarks of their contributions across…